Remove 2023 Remove IPO Remove Valuation
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

Unlike in 2023, when a Q4 dealmaking binge over the holidays led to the sector outperforming the market, life sciences M&A cut down and stuck with it throughout 2024. from 2023. [1] billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023.

M&A
article thumbnail

A bullish breakout in this little-known pharma stock is forming, charts show

CNBC: Investing

The prior breakout occurred near $32, where rally attempts had been snuffed out multiple times since 2023. shortly after its IPO in mid-2020. However, the sell-off helped reset expectations, valuations, and sentiment—creating a potential springboard if this pattern can be leveraged. The stock reached a high of $56.50

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Frequently Asked Questions for Private Companies Considering a Reverse Merger

JD Supra: Mergers

*This piece appears in PitchBook’s 2023 Annual US VC Valuations Report. We believe this is the wrong question—we view a reverse merger as "going public" during your cross-over round, rather than as an alternative to an IPO. By: Mintz - Securities & Capital Markets

article thumbnail

The 3rd Fintech Epoch: Europe’s first-movers drive M&A amid tightened purse strings

JD Supra: Mergers

UK & European Financial Services M&A: Sector trends H2 2022 | H1 2023 — Fintech - Whilst many European start-ups have struggled to successfully execute funding rounds at valuation levels of yesteryear, more mature fintechs have pivoted to acquisitions and partnerships to fuel growth. By: White & Case LLP

M&A
article thumbnail

Venture Capital: Annual VC Valuations Report

Deal Lawyers

PitchBook recently published its 2023 Venture Capital Valuations Report, and not surprisingly, the news is pretty grim. VC valuations continued to head south from their 2021-22 levels. Not surprisingly, exit prospects weren’t great either.

article thumbnail

Upgrade acquires travel-focused BNPL startup Uplift for a song

TechCrunch: M&A

Uplift had raised nearly $700 million in equity and debt, securing $123 million at a reported $195 million valuation in its Series C round alone. Klarna , once Europe’s most valuable VC-backed company, suffered an 85% valuation cut, from $45.6 million users to the platform, and comes as Upgrade weighs an IPO.

article thumbnail

10-20-2023 Newsletter: Why PE Investors Care About Inflation

OfficeHours

Furthermore, if the portfolio company’s revenue is not able to increase with or outpace the rate at which inflation is rising, its valuation will ultimately be impacted. High inflation might make IPOs more attractive as public markets can provide better protection against inflation whereas selling to strategic buyers or secondary buyers (i.e.